FDA Adverse Event Malfunction Summary report: N

REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION

MDR report key: 24257549 · Received February 4, 2026

Report

Report Number
3016798778-2026-00020
Event Type
Malfunction
Date Received
February 4, 2026
Date of Event
January 7, 2026
Report Date
February 4, 2026
Manufacturer
MILLYARD ADVANCED MEDICAL PRODUCTS, LLC
Product Code
QJY
UDI-DI
00850017421035
PMA / PMN Number
K202690
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

EFFORTS TO OBTAIN ADDITIONAL INFORMATION RELEVANT TO THE REPORTED EVENT FROM ACCREDO HEALTH GROUP, INC., WERE UNSUCCESSFUL. AT THE TIME OF THIS REPORT, NO COMPONENTS OR ADDITIONAL INFORMATION HAVE BEEN MADE AVAILABLE TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC, FOR FURTHER INVESTIGATION.

Description of Event or Problem · 0

AN INITIAL EVENT NOTIFICATION WAS RECEIVED BY UNITED THERAPEUTICS DRUG SAFETY ON 09-JAN-2026 FROM ACCREDO HEALTH GROUP, INC., AND FORWARDED TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC ON 10-JAN-2026. IT WAS REPORTED THAT ONE OF THE PATIENT'S REMUNITY PUMPS WAS NOT FUNCTIONING AS EXPECTED, AND THEY WERE ADMITTED TO THE HOSPITAL. NO FURTHER DETAILS REGARDING THE SPECIFIC DEVICE ISSUE WERE PROVIDED. THE PATIENT RECEIVED SUBCUTANEOUS REMODULIN AND REMAINED HOSPITALIZED FROM (B)(6) 2026 UNTIL DISCHARGE ON (B)(6) 2026.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
318737 REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION INFUSION PUMP QJY MILLYARD ADVANCED MEDICAL PRODUCTS, LLC DKPI-11042-001 00850017421035

Patients

Seq Age Sex Outcome Treatment
1 53 YR Female Hospitalization ALBUTEROL HFA| ALBUTEROL SULF INH SOL| AMITRIPTYLINE USP| CITALOPRAM HBR| CLONIDINE USP| FAMOTIDINE| FUROSEMIDE| GABAPENTIN USP| KETAMINE HCL USP| KETOPROFEN USP| LECITHIN| LIDOCAINE HCL USP| LOSARTAN POTASSIUM| OXYGEN| PANTOPRAZOLE SOD DR| POLOXAMER GEL| SYMBICORT